id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0125-0025,FDA,FDA-2013-N-0125,Guidance for Industry Alternative to Certain Prescription Device Labeling Requirements,Other,Guidance,2020-05-18T04:00:00Z,2020,5,2020-05-18T04:00:00Z,,2024-11-06T23:36:54Z,,1,0,0900006484635b8a
FDA-2013-N-0125-0024,FDA,FDA-2013-N-0125,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals",Notice,Notice of Approval,2016-12-19T05:00:00Z,2016,12,2016-12-19T05:00:00Z,,2016-12-19T15:46:41Z,2016-30351,0,0,09000064824264d3
FDA-2013-N-0125-0023,FDA,FDA-2013-N-0125,Reference 6 Final Regulatory Impact Analysis re Use of Certain Symbols in Labeling,Supporting & Related Material,Background Material,2016-07-22T04:00:00Z,2016,7,,,2016-07-22T18:53:41Z,,0,0,09000064820f48bd
FDA-2013-N-0125-0017,FDA,FDA-2013-N-0125,Index List of References re Use of Symbols in Labeling,Supporting & Related Material,Background Material,2016-06-15T04:00:00Z,2016,6,,,2016-06-15T14:54:49Z,,0,0,090000648203df63
FDA-2013-N-0125-0018,FDA,FDA-2013-N-0125,Reference 1 Frequently Asked Questions Guidance re Use of Symbols in Labeling,Supporting & Related Material,Background Material,2016-06-15T04:00:00Z,2016,6,,,2016-06-15T14:56:37Z,,0,0,090000648203f737
FDA-2013-N-0125-0019,FDA,FDA-2013-N-0125,Reference 2 National Technology Transfer  Act re Use of Symbols in Labeling,Supporting & Related Material,Background Material,2016-06-15T04:00:00Z,2016,6,,,2016-06-15T14:59:00Z,,0,0,090000648203f738
FDA-2013-N-0125-0016,FDA,FDA-2013-N-0125,Use of Symbols in Labeling,Rule,Final Rule,2016-06-15T04:00:00Z,2016,6,2016-06-15T04:00:00Z,,2016-06-15T14:38:00Z,2016-13989,0,0,090000648203d414
FDA-2013-N-0125-0020,FDA,FDA-2013-N-0125,Reference 3 Circular A119 re Use of Symbols in Labeling,Supporting & Related Material,Background Material,2016-06-15T04:00:00Z,2016,6,,,2016-06-15T15:00:44Z,,0,0,090000648203f739
FDA-2013-N-0125-0021,FDA,FDA-2013-N-0125,Reference 4 IVD Symbols Guidance re Use of Symbols in Labeling,Supporting & Related Material,Background Material,2016-06-15T04:00:00Z,2016,6,,,2016-06-15T15:02:30Z,,0,0,090000648203f73a
FDA-2013-N-0125-0022,FDA,FDA-2013-N-0125,06 Reference 5 Alternative to Prescription Device Labeling Guidance re Use of Symbols in Labeling,Supporting & Related Material,Background Material,2016-06-15T04:00:00Z,2016,6,,,2016-06-15T15:04:45Z,,0,0,090000648203f73b
FDA-2013-N-0125-0001,FDA,FDA-2013-N-0125,Use of Certain Symbols in Labeling,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2013-04-19T04:00:00Z,2013,4,2013-04-19T04:00:00Z,2013-06-19T03:59:59Z,2013-06-25T01:28:35Z,2013-09175,0,0,090000648129c6c1